HERON THERAPEUTICS, INC. /DE/ ·
HRTX 8-K 2026-09-29
HERON THERAPEUTICS, INC. /DE/ (HRTX) 8-K dated 2026-09-29 — accession 0001193125-26-407728.
HERON THERAPEUTICS, INC. /DE/ (HRTX) is a biotechnology company listed on US.
HERON THERAPEUTICS, INC. /DE/ filed a 8-K on 2026-09-29. Accession 0001193125-26-407728.
This 8-K covers: Material agreement (Item 1.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported HRTX revenue for 2025-12-31 was $154.9M. Net income was -$20.2M. Revenue was up 7.4% from 2024-12-31 to 2025-12-31. HRTX currently screens at market cap $332.6M.
Not investment advice. The HRTX SEC hub lists recent forms. The stock page is the research view.